Markets are buzzing with action every day – stocks rising, deals happening, and companies making key announcements. But with so much going on, it is easy to lose track of what really matters. We have got you covered. From massive fundraisings to key approvals and major deals, here are the stocks that will be in focus for today’s trading session.

Indian equity markets ended on a strong note on March 17, with benchmark indices closing in the green. The Sensex jumped 1,131.30 points or 1.53% to settle at 75,301.26, while the Nifty gained 325.55 points or 1.45% to close at 22,834.30

Bajaj Auto board has reappointed Rajiv Bajaj as MD & CEO for another five years, starting April 1, 2025. In addition, the company has approved an additional Rs 1,500 crore infusion into Bajaj Auto Credit Ltd to strengthen its financial arm.

State-run Life Insurance Corporation of India (LIC) has officially confirmed its plans to expand into the health insurance space. In a regulatory filing, LIC stated that it is in advanced talks to acquire a substantial stake in a standalone health insurance company.

Power giant NTPC is gearing up to raise Rs 4,000 crore by issuing non-convertible debentures (NCDs) on March 20. These NCDs, with a 15-year tenure, will offer a 7.26% annual coupon rate. The funds will be used for capital expenditure, loan refinancing, and general corporate needs.

Infrastructure giant Larsen & Toubro (L&T) has lined up a board meeting on March 21, 2025, to discuss a potential fundraising through a debt issue. In a regulatory filing, the company confirmed that its board will consider the proposal for raising funds via debt instruments.

Infra major GR Infraprojects has secured a major contract from NHAI for a highway project worth Rs 4,262.78 crore. The project involves building and improving the Agra-Gwalior road, spanning across Uttar Pradesh, Rajasthan, and Madhya Pradesh. The deal includes developing a six-lane expressway and upgrading an existing stretch of NH-44.

Brigade Enterprises and Gruhas, co-founded by Zerodha’s Nikhil Kamath, are stepping into the future of real estate. They’ve launched Earth Fund, a Rs 200 crore investment platform focused on proptech and sustainability-driven startups. The SEBI-registered fund aims to support startups solving critical challenges in real estate, construction, and green tech.

Zydus Lifesciences has received final approval from the USFDA to manufacture and market apalutamide tablets (generic version of Erleada). This drug is used to treat metastatic castration-sensitive prostate cancer. The tablets will be produced at Zydus’ Ahmedabad facility.

Hindustan Zinc

It’s a rough patch for Hindustan Zinc. The Vedanta Group subsidiary has been fined Rs 5.42 lakh each by BSE and NSE for failing to meet board composition norms. The penalty comes due to a shortfall in the required number of Independent Directors, as per SEBI’s listing regulations.